Table 2

Haemodynamics, renal function and mortality in patients with cardiac index above or below 1.5 l/min/m2

CI<1.5 n = 8CI>1.5 n = 16p Value
SV, ml38 (9)55 (17)0.02
SVI, ml/m221.4 (4.7)30.5 (8.0)0.01
MAP, mmHg83.0 (15.0)89.9 (13.0)0.26
HR, min−163 (10)77 (14)0.009
AC, ml/mmHg1.02 (0.34)1.12 (0.47)0.63
SVR, Newton s cm−50.02924 (0.00808)0.01884 (0.00660)0.004
QTc, s½0.436 (0.029)0.429 (0.029)0.57
Serum proANP, pg/ml1874 (2818)1117 (2230)0.03
Serum proBNP, pg/ml717 (4185)602 (3681)0.72
RBF, ml/min352 (232)561 (229)0.06
GFR, ml/min39 (24)63 (23)0.03
CNa, ml/min0.31 (0.30)0.86 (0.80)0.03
FeNa, %0.005 (0.005)0.011 (0.0090.047
CLi, ml/min8.0 (5.6)15.4 (9.0)0.058
log serum aldosterone, pmol/l3.21 (2.06)2.66 (2.15)0.08
Plasma renin, pg/ml86 (3996)20 (1207)0.28
Serum creatinin, μmol/l130 (46)78 (29)0.003
Dead <3 months4/81/160.01
Hepatorenal syndrome type 1 <3 months3/7*1/160.04
Dead <9 months5/82/160.006
Dead <12 months5/84/160.03
  • Results are given as mean (SD) or median (range).

  • *One patient died outside hospital.

  • AC, arterial compliance; CLi, lithium clearance; CNa, sodium clearance; FeNa, fractional sodium excretion; GFR, glomerular filtration rate; HR, heart rate; MAP, mean arterial pressure; Pro ANP, pro atrial natriuretic peptide; Pro BNP, pro brain natriuretic peptide; QTc, QT interval corrected for heart rate; RBF, renal blood flow; SV, stroke volume; SVI, stroke volume index; SVR, systemic vascular resistance.